Puma Biotechnology (NYSE:PBYI) presents at ASCO thepositive results from an ongoing Phase II clinical trial of Puma's investigational drug PB272 for the treatment of HER2-positive metastatic breast cancer that has metastasized to the brain. The multicenter Phase II clinical trial enrolled patients with HER2-positive metastatic breast cancer who have brain metastases. The trial is being performed by the TBCRC and enrolled three cohorts of patients. We are very pleased with the activity seen in this trial with the combination of neratinib plus capecitabine, sys Puma CEOAlan Auerbach. As a small molecule that can cross the blood brain barrier, neratinib potentially offers patients with HER2-positive metastatic breast cancer that has metastasized to the CNS a novel HER2 targeted treatment option. We look forward to working with TBCRC on future trials of neratinib in patients with HER2-positive disease metastatic to the CNS," he adds. Source: Press Release #ASCO Excerpt from: Puma Biotechnology announces positive trial results - Seeking Alpha … Continue reading →

A post-secondary program in biotechnology opens doors to various careers in clinical research, DNA analysis, quality control and assurance, industrial microbiology and biochemistry, biology instrumentation and calibration. The graduates of this program demonstrate the ability to Isolate, enumerate and identify microorganisms Collect and store samples Prepare specimen for staining Prepare microbiological media and reagents and culture pathogenic microbes Design and perform microbiology experiments Sample, measure, collect and analyze data Calibrate and use laboratory instruments Apply appropriate safety procedures Handle hazardous chemicals The professionals can find employment in food, pharmaceutical and cosmetic industries as biotechnology technicians, lab technicians, biology lab assistants, life science lab technicians and instrumentation and calibration assistants. They can also work with companies into clinical research, quality testing and biotechnology product development. Choosing a Biotechnology College in Canada How you start your career depends on where you have studied, to a great extent. The biotechnology programs that have met the national technology accreditation requirements established by the Canadian Council of Technicians and Technologists (CCTT) and the Canadian Technology Accreditation Board (CTAB) offer better placement opportunities. It is important to ask the following questions before enrolling into a biotechnology college or course in Canada: Is the program accredited by … Continue reading →

Investorplace.com iShares NASDAQ Biotechnology Index (IBB) Downgraded by Vetr Inc. to "Hold" The Cerbat Gem iShares NASDAQ Biotechnology Index logo iShares NASDAQ Biotechnology Index (NASDAQ:IBB) was downgraded by equities research analysts at Vetr from a buy rating to a hold rating in a report issued on Monday. They presently have a $307.00 target ... Trade of the Day: iShares Nasdaq Biotechnology Index (ETF) (IBB)Investorplace.com iShares NASDAQ Biotechnology Index (IBB) Given News Impact Score of 0.10Sports Perspectives First Personal Financial Services Lowers Position in iShares NASDAQ Biotechnology Index (IBB)BBNS Chaffey Breeze -Stock Observer -BNB Daily (blog) all 73 news articles » See original here: iShares NASDAQ Biotechnology Index (IBB) Downgraded by Vetr Inc. to "Hold" - The Cerbat Gem … Continue reading →

A Toronto Stock Exchange (TSX) logo is seen in Toronto November 9, 2007. (Mark Blinch / Reuters) A Toronto Stock Exchange (TSX) logo is seen in Toronto November 9, 2007. (Mark Blinch / Reuters) Subscribers Only Sean Silcoff OTTAWAThe Globe and Mail Published Sunday, Jun. 04, 2017 3:36PM EDT Last updated Sunday, Jun. 04, 2017 3:39PM EDT The Canadian biotechnology business is a picture of good health. On Friday, management of Vancouver-based cancer therapy developer Zymeworks Inc. rang the bell on the Toronto Stock Exchange, five weeks after its stock debuted in a $59-million (U.S.) initial public offering in Canada and on the New York Stock Exchange. It was by far the largest biotech IPO on a Canadian exchange in a decade and came on the heels of one of the largest stock offerings ever by a Canadian biotech firm, after dual-listed lupus-drug developer Aurinia Pharmaceuticals Inc. raised $150.5-million in March. To continue reading this article, you must be a Globe Unlimited subscriber. Subscribe to Globe Unlimited now! Follow Sean Silcoff on Twitter: @SeanSilcoff Trudeau says Ottawa wont legalize illicit drugs other than marijuana (The Canadian Press) Discover content from The Globe and Mail that you might otherwise not have … Continue reading →

Biotechnology Technicians (also known as bench technicians) have the distinct job of assuring quality control in areas of manufacturing such as food, pharmaceuticals and cosmetics. These areas in which humans consume or use products are very important and require the utmost attention. Therefore, biotechnology technicians must attend a biotechnology college program before entering the field. If the field sounds like one in which you may have interest, Centennial College in Toronto, Ont. offers a two year Biotechnology Technician Industrial Microbiology program. Students are provided with thorough practical training in industrial microbiology as well as chemistry (analytical and organic) and biochemistry. As with all Centennial College programs, there are prerequisites to attending. First, students must present at minimum an Ontario Secondary School Diploma (OSSD) or equivalent or be 19 years of age or older. Also required is completion of compulsory English 12C or U or skills assessment, or equivalent and Math 11M or U or 12C or U or skills assessment, or equivalent. Students are placed in appropriate English level based on skills assessment results. Lastly, students who test at an advanced level may be accelerated directly into MATH-176 in semester 1 and MATH-186 in semester 2. Those taking MATH-140 will … Continue reading →